Teva Pharmaceutical Industries (TEVA) Net Cash Flow Growth (1y) (2018 - 2026)
Teva Pharmaceutical Industries (TEVA) Net Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.52 Bn | 35.79 Bn | 1.97 Bn | 112.26% |
| 2 | Zoetis | 33.53 Bn | 31.59 Bn | 1.62 Bn | -44.11% |
| 3 | United Therapeutics | 23.92 Bn | 21.77 Bn | 648.10 Mn | -236.85% |
| 4 | Aurora Cannabis | 16.96 Bn | 16.88 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.47 Bn | 15.15 Bn | 800.70 Mn | -1,047.81% |
| 6 | Elanco Animal Health | 11.76 Bn | 11.33 Bn | 785.00 Mn | -1,020.00% |
| 7 | Alkermes | 7.11 Bn | 6.60 Bn | -116.06 Mn | -807.00% |
| 8 | Lantheus Holdings | 6.53 Bn | 6.03 Bn | 230.92 Mn | 444.33% |
| 9 | Hims & Hers Health | 5.98 Bn | 5.23 Bn | 396.79 Mn | -107.45% |
| 10 | Liquidia | 5.44 Bn | 5.22 Bn | 121.79 Mn | 577.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 112.26% |
| Dec 31, 2025 | 1,223.30% |
| Sep 30, 2025 | -94.69% |
| Jun 30, 2025 | 168.47% |
| Mar 31, 2025 | -1,158.02% |
| Dec 31, 2024 | -88.67% |
| Sep 30, 2024 | 348.32% |
| Jun 30, 2024 | -219.96% |
| Mar 31, 2024 | 80.45% |
| Dec 31, 2023 | 111.40% |
| Sep 30, 2023 | -254.18% |
| Jun 30, 2023 | 1,686.11% |
| Mar 31, 2023 | -687.72% |
| Dec 31, 2022 | 113.93% |
| Sep 30, 2022 | 169.72% |
| Jun 30, 2022 | -105.16% |
| Mar 31, 2022 | 129.23% |
| Dec 31, 2021 | -42.07% |
| Sep 30, 2021 | 39.29% |
| Jun 30, 2021 | 19.73% |